1. Home
  2. HCAT

as 04-18-2025 1:37pm EST

$
-
.
-
-
+
$
-
.
-
-
+
-
.
-
-
%

Stocks

Technology

Computer Software: Programming Data Processing

Nasdaq

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Founded: 2008 Country:
United States
United States
Employees: N/A City: SOUTH JORDAN
Market Cap: 259.8M IPO Year: 2019
Target Price: $8.36 AVG Volume (30 days): 623.1K
Analyst Decision: Buy Number of Analysts: 11
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -1.15 EPS Growth: N/A
52 Week Low/High: $3.60 - $9.24 Next Earning Date: 05-07-2025
Revenue: $306,584,000 Revenue Growth: 3.60%
Revenue Growth (this year): 11.3% Revenue Growth (next year): 9.79%

HCAT Daily Stock ML Predictions

Stock Insider Trading Activity of Health Catalyst Inc (HCAT)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
LeSueur Daniel HCAT Chief Operating Officer Apr 3 '25 Sell $4.15 5,209 $21,604.33 211,041
Landry Benjamin HCAT General Counsel Mar 6 '25 Sell $4.55 13,827 $62,860.31 160,437
LeSueur Daniel HCAT Chief Operating Officer Mar 5 '25 Sell $4.52 16,902 $76,331.12 211,041
Llewelyn Linda HCAT Chief People Officer Feb 18 '25 Sell $5.43 6,441 $34,952.73 85,819
LeSueur Daniel HCAT Chief Operating Officer Feb 5 '25 Sell $5.76 5,209 $30,007.49 211,041

Share on Social Networks: